Navigating the crossroads: cardiometabolic risks in cancer survivorship - a comprehensive review
- PMID: 38879583
- PMCID: PMC11179285
- DOI: 10.1186/s40959-024-00240-2
Navigating the crossroads: cardiometabolic risks in cancer survivorship - a comprehensive review
Abstract
The landscape of cancer survivorship is increasingly populated by individuals facing a spectrum of cardiometabolic risks, attributed to both their oncological history and treatment regimens. This manuscript synthesizes findings from various studies, highlighting the prevalence of traditional risk factors-hypertension, dyslipidemia, diabetes-as well as emergent concerns like obesity and metabolic syndrome among survivors. The impact of demographic variables, specific cancer types, and treatment modalities on cardiometabolic health is explored. Through a lens of multidisciplinary management and future research directives, we advocate for an integrative approach to cardiometabolic health in cancer survivors, aiming to ensure their victory over cancer extends into long-term well-being.
Keywords: Cancer Survivorship; Cardiometabolic Risks; Cardiovascular Disease; Multidisciplinary Management; Oncologic Treatment.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that there are no conflicts of interest regarding the publication of this manuscript. All authors have reviewed the content and have agreed to the submission. There are no financial or other relationships that might lead to a perceived conflict of interest.
Figures
Similar articles
-
Retraction Note: Navigating the crossroads: cardiometabolic risks in cancer survivorship - a comprehensive review.Cardiooncology. 2025 Jan 23;11(1):6. doi: 10.1186/s40959-025-00306-9. Cardiooncology. 2025. PMID: 39849640 Free PMC article. No abstract available.
-
Navigating the crossroads: cardiometabolic risks in cancer survivorship - a comprehensive review.Cardiooncology. 2024 Aug 13;10(1):51. doi: 10.1186/s40959-024-00254-w. Cardiooncology. 2024. Retraction in: Cardiooncology. 2025 Jan 23;11(1):6. doi: 10.1186/s40959-025-00306-9. PMID: 39138547 Free PMC article. Retracted. Review.
-
Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.BMC Cancer. 2017 Nov 10;17(1):751. doi: 10.1186/s12885-017-3722-6. BMC Cancer. 2017. PMID: 29126409 Free PMC article.
-
Cardiometabolic Health Among Cancer Survivors: A 13-Week Pilot Study of a Combined Aerobic and Resistance Training Program.Oncol Nurs Forum. 2016 May 1;43(3):306-15. doi: 10.1188/16.ONF.306-315. Oncol Nurs Forum. 2016. PMID: 27105192
-
The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts.Sex Med. 2020 Jun;8(2):132-155. doi: 10.1016/j.esxm.2020.02.006. Epub 2020 Mar 20. Sex Med. 2020. PMID: 32201216 Free PMC article. Review.
Cited by
-
Retraction Note: Navigating the crossroads: cardiometabolic risks in cancer survivorship - a comprehensive review.Cardiooncology. 2025 Jan 23;11(1):6. doi: 10.1186/s40959-025-00306-9. Cardiooncology. 2025. PMID: 39849640 Free PMC article. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources